BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36358690)

  • 1. Rosai-Dorfman Disease between Proliferation and Neoplasia.
    Elbaz Younes I; Sokol L; Zhang L
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary intraosseous Rosai-Dorfman disease: An analysis of clinicopathologic characteristics, molecular genetics, and prognostic features.
    Weng X; Yang Y; Zhang M; Cai C; Sun Y; Wu X; Zhang R; Gui H; Li W; Xu Q; Liu X
    Front Oncol; 2022; 12():950114. PubMed ID: 36185213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated intracranial rosai-dorfman disease involving the meninges: report of a rare case.
    Bhat A; Kupanur SS; Geethamani V
    Turk Neurosurg; 2015; 25(1):186-9. PubMed ID: 25640569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
    Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
    Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosai-Dorfman disease of the breast: a clinicoradiologic and pathologic study.
    Wang Q; Bradley K; Zhang M; Li S; Li X
    Hum Pathol; 2023 Nov; 141():30-42. PubMed ID: 37673345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sinus histiocytosis with massive lymphadenopathy (rosai-dorfman disease): a case report and literature review.
    Pradhananga RB; Dangol K; Shrestha A; Baskota DK
    Int Arch Otorhinolaryngol; 2014 Oct; 18(4):406-8. PubMed ID: 25992132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS 117N positive Rosai-Dorfman disease with atypical features.
    Jafri ZA; Reddy SP; Cassarino DS
    J Cutan Pathol; 2021 Jan; 48(1):147-150. PubMed ID: 32974961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong Coexpression of Transcription Factors PU.1 and Oct-2 in Rosai-Dorfman Disease.
    Kiruthiga KG; Younes S; Natkunam Y
    Am J Clin Pathol; 2022 Dec; 158(6):672-677. PubMed ID: 36239684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosai-Dorfman-Destombes disease - histiocytic disorder with inflammatory manifestation.
    Adam Z; Adamová Z; Pour L; Řehák Z; Koukalová R; Král Z
    Klin Onkol; 2022; 35(4):262-170. PubMed ID: 35989082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai-Dorfman Disease.
    Tang M; Gu XZ; Wu PC; Yang XT
    J Inflamm Res; 2022; 15():2775-2787. PubMed ID: 35518839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases].
    Dong RF; Gong LH; Zhang W; Li L; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):904-909. PubMed ID: 32892555
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy.
    Paryani NN; Daugherty LC; O'Connor MI; Jiang L
    Rare Tumors; 2014 Oct; 6(4):5531. PubMed ID: 25568748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rosai-Dorfman disease: clinicopathologic, immunohistochemical and etiologic study of 16 cases].
    Yu JB; Liu WP; Zuo Z; Tang Y; Liao DY; Ji H; Bai YQ; Li SH; Lu CQ; Luo HB
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):33-8. PubMed ID: 17374236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
    Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
    Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Cause of Lymphadenopathy in a Young Hispanic Female: Unmasking Recurrent Nodal Rosai-Dorfman Disease.
    Alexander B; Alshaikhli A; Bartl M; Ng-Wong YK; Dulgheru EC
    Cureus; 2023 May; 15(5):e39131. PubMed ID: 37378192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature.
    McIntire PJ; Kilic AI; Chen HH; Atieh M; Wojcik EM; Pambuccian SE
    J Am Soc Cytopathol; 2019; 8(4):190-205. PubMed ID: 31272602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Unusual Tumor in an Uncommon Site-Orbital Rosai-Dorfman Disease: A Case Report.
    Hansdah R; Kushwaha A; Saxena SK; Jinkala S; Alexander A
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5584-5587. PubMed ID: 36742722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
    Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
    Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.